statementSaid on 2026-11-10
Response to 헥토헬스케어's premium new products is favorable and the product portfolio is being expanded.
A statement by post author, said on 2026-11-10. Statements are as reported by the cited publishers — not verified by DecisionGateway.
헥토헬스케어(헬스케어) 프리미엄 신제품 반응 양호 및 제품 포트폴리오 확대
Discussion
Related claims
헥토이노베이션 achieved a record quarterly operating profit in 3Q26 on the back of high growth at its fintech and healthcare subsidiaries.post author · statement헬스케어 revenue was 238억원 (-0.1%), falling short of expectations on top-line growth but improving profitability versus the prior quarter.3Q26 Review · statementThe purchase of another fast-growing platform to expand the holding's product line looks logical.Эйлера · statementHealth insurance coverage has expanded significantly.Nigeria · statementCiti now favors healthcare and materials.Citi · statementNew service expansion and a profitability-focused portfolio reorganization are continuing, and valuation attractiveness has risen further with the recent share price decline.post author · statement